GET THE APP

..

Journal of Lung Diseases & Treatment

ISSN: 2472-1018

Open Access

About the Journal

Journal of Lung Diseases and Treatment is an open access journal and publishes the manuscripts after thorough peer review. It handles the etiology, diagnosis and treatment of lung diseases which includes Lung Cancer Treatment, Lung Inflammation and Treatment, Lung Parenchyma, Lung Radiation Therapy, Lung Fibrosis, COPD Treatment, Lung Infection and Treatment, etc. This journal also displays the advanced and innovative treatment techniques related to lung diseases.

The main aim of this journal is to develop the targeted drug delivery to lung diseases and encourage the research scholars, scientists and physicians in this particular field of medical research. This journal also provides the latest updates on research and advanced treatment techniques in lung diseases.

Open access journal is a platform, in which all articles are printed online with rapid peer review process and anyone in the world can access it with free of cost.

This medical journal is using Editorial Tracking System for online manuscript submission, review and tracking. Editorial board members of the lung diseases and treatment and outside experts review the manuscripts; at least two independent reviewers approval followed by editor approval is required for acceptance of manuscript for publication.

Inflammation is an essential component of many lung diseases. Lung inflammation can refer to irritation and infection of the lung.

  • Pleurisy: The pleural sacs become inflamed that condition called pleurisy.
  • Pneumonia: The lung tissue itself becomes infected, usually due to bacteria. It is one of the main reasons for lung inflammation.

Lung inflammation can lead to the formation of a lung abscess, a pus-filled cavity surrounded by inflammation, or an empyema, a collection of pus in the pleural space. Both these complications are very serious conditions that need antibiotic treatment, and maybe even surgery to remove the abscess or drain the pus. Another extreme consequence of pneumonia is acute respiratory distress syndrome, which can be fatal. The lung's air sacs fill with fluid, and the respiratory failure ensures. This complication has a high fatality rate and requires a patient to be in an intensive care unit, receiving aggressive treatment including receiving extra oxygen with the help of a ventilator and antibiotics.

Related Journals of Lung Inflammation and Treatment
Pulmonary & Respiratory Medicine, Lung Diseases & Treatment, Inflammatory mechanisms in the lung, European Respiratory Journal, Lymphoma, Journal of Asthma & Bronchitis, Journal of Lung Cancer Diagnosis & Treatment, Insights in chest diseases, International Journal of Tuberculosis and Lung Disease, Open Journal of Respiratory Diseases, Journal Rankings on Pulmonary and Respiratory Medicine, The International Journal of Tuberculosis and Lung Disease, Journal Of Respiratory Diseases, Tubercle and Lung Disease, Respiratory Medicine, European Respiratory, International Journal of Chronic Obstructive Pulmonary, The Journal of respiratory diseases, Chronic Respiratory Disease, Lung India, Infectious Pulmonary Diseases

Lung parenchyma is the medical term used to describe the exact functioning parts of a human or animal lung. It includes the alveolar walls as well as the blood vessels and the bronchi. If any part of the parenchyma becomes damaged or diseased, a person’s life may be at risk.

Related Journals of Lung Parenchyma
Pulmonary & Respiratory Medicine, Lung Compliance and Chronic Obstructive Pulmonary, Journal of Cardiac Surgery, Lung Diseases & Treatment, Inflammatory mechanisms in the lung, European Respiratory Journal, Insights in chest diseases, Journal of Asthma & Bronchitis, Journal of Lung Cancer Diagnosis & Treatment, International Journal of Tuberculosis and Lung Disease, Open Journal of Respiratory Diseases, Journal Rankings on Pulmonary and Respiratory Medicine, The International Journal of Tuberculosis and Lung Disease, Journal Of Respiratory Diseases, Tubercle and Lung Disease, Respiratory Medicine, European Respiratory, International Journal of Chronic Obstructive Pulmonary, The Journal of respiratory diseases, Chronic Respiratory Disease, Lung India, Infectious Pulmonary Diseases

Rapid Publication Service

Hilaris Publishing is offering wide range of opportunities, options and services for the prospective authors to publish their scholarly contributions.

The journal caters to the demands of the fast publication without compromising on the editorial quality including manuscript peer-review. This flexibility is being provided to ensure earliest author credibility to their respective contributions and this will also ensure timely dissemination of research outcomes for efficient integration, effective translation and reduced redundancy.

Authors have the option to choose between the standard open access publication service which takes its own course of time for complete publication process or can opt for rapid publication service wherein the article is published at the earliest date (Includes multiple subject experts commissioning for securing earliest peer-review comments). The authors can avail this flexibility based on the personal preference, funding agency guidelines or Institutional or organizational requirements.

Regardless of the option, all manuscripts undergo thorough peer-review process, editorial assessment and production process.

Submit manuscript at https://www.scholarscentral.org/submissions/lung-diseases-treatment.html or send as an e-mail attachment to the Editorial Office at  lungdiseases@journalinsight.org

Fast Editorial Execution and Review Process (FEE-Review Process)

Authors who are willing to publish their articles under this mode can make a pre-payment of $99 towards express peer-review and editorial decision. First editorial decision in 3 days and final decision with review comments in 5 days from the date of submission. Galley proof generation will be done in next 2 days from acceptance or maximum 5 days (For manuscripts notified for revision by external reviewer).

Manuscripts accepted for publication will be charged regular APC.

Authors retain the copyright of their publication and the final version of the article will be published in both HTML and PDF formats as well as XML formats for transmitting to indexing databases. The editorial team of the Journal will ensure adherence to scientific publication guidelines.

h-index

Articles published in Journal of Lung Diseases & Treatment have been cited by esteemed scholars and scientists all around the world. Journal of Lung Diseases & Treatment has got h-index 6 , which means every article in Journal of Lung Diseases & Treatment has got 6 average citations.

Recent Articles

Relevant Topics

arrow_upward arrow_upward